| During the period, the Company granted 3,704 ordinary shares to an adviser providing services to the Company under an equity-settled share-based payment arrangement.
The shares were granted on 31 March 2025 with a fair value of £4.50 per share, determined by reference to the Company's most recent funding round. Shares vest on a straight-line basis over a 24 month period, subject to the adviser continuing to provide services throughout the vesting period.
The fair value of the shares vested during the period was £2,778 and this was charged to the Profit and Loss account as an expense. The total carrying amount of £2,778 of the vested shares has been recognised in 'Other Reserves'.
No share options were exercised, no share options were forfeited and no share options expired during the period. The total number of share options outstanding at the period end is 3,704 (2024: nil). |